Found: 55
Select item for more details and to access through your institution.
Cyclophosphamide-based combination therapies for autoimmunity.
- Published in:
- Neurological Sciences, 2008, v. 29, p. 233, doi. 10.1007/s10072-008-0947-9
- By:
- Publication type:
- Article
Alemtuzumab following natalizumab in highly active paediatric-onset multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2019, v. 5, n. 3, p. 1, doi. 10.1177/2055217319875471
- By:
- Publication type:
- Article
Multiple Sclerosis Incidence and Prevalence Trends in the Province of Padua, Northeast Italy, 1965–2018.
- Published in:
- Neuroepidemiology, 2019, v. 52, n. 1/2, p. 41, doi. 10.1159/000493857
- By:
- Publication type:
- Article
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, p. 1, doi. 10.1177/17562864231177196
- By:
- Publication type:
- Article
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2023, v. 16, p. 1, doi. 10.1177/17562864231177196
- By:
- Publication type:
- Article
Early red nucleus atrophy in relapse‐onset multiple sclerosis.
- Published in:
- Human Brain Mapping, 2021, v. 42, n. 1, p. 154, doi. 10.1002/hbm.25213
- By:
- Publication type:
- Article
Cover Image.
- Published in:
- Human Brain Mapping, 2021, v. 42, n. 1, p. 1, doi. 10.1002/hbm.25048
- By:
- Publication type:
- Article
A potential protective role of magnesium in neuroCOVID.
- Published in:
- Magnesium Research, 2022, v. 35, n. 1, p. 18, doi. 10.1684/mrh.2022.0497
- By:
- Publication type:
- Article
Neurocovid and magnesium.
- Published in:
- Magnesium Research, 2021, v. 34, n. 3, p. 156
- By:
- Publication type:
- Article
Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 4, p. 546, doi. 10.1177/1352458517714610
- By:
- Publication type:
- Article
Cortical relapses in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 9, p. 1184, doi. 10.1177/1352458514564483
- By:
- Publication type:
- Article
MRI-detectable cortical lesions in the cerebellum and their clinical relevance in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2016, v. 22, n. 4, p. 494, doi. 10.1177/1352458515594043
- By:
- Publication type:
- Article
A case of relapsing–remitting tumour-like inflammation of the central nervous system.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Low degree of cortical pathology is associated with benign course of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 7, p. 904, doi. 10.1177/1352458512463767
- By:
- Publication type:
- Article
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 2, p. 174, doi. 10.1177/1352458511418550
- By:
- Publication type:
- Article
Designing a Self-Perception Cognitive Questionnaire for Italian Multiple Sclerosis Patients (Sclerosi Multipla Autovalutazione Cognitiva, SMAC). A Preliminary Exploratory Pilot Study.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.668933
- By:
- Publication type:
- Article
Therapy of Pediatric-Onset Multiple Sclerosis: State of the Art, Challenges, and Opportunities.
- Published in:
- Frontiers in Neurology, 2021, v. 11, p. N.PAG, doi. 10.3389/fneur.2021.676095
- By:
- Publication type:
- Article
Extensive cortical inflammation is associated with epilepsy in multiple sclerosis.
- Published in:
- Journal of Neurology, 2008, v. 255, n. 4, p. 581, doi. 10.1007/s00415-008-0752-7
- By:
- Publication type:
- Article
Cortical atrophy is relevant in multiple sclerosis at clinical onset.
- Published in:
- Journal of Neurology, 2007, v. 254, n. 9, p. 1212, doi. 10.1007/s00415-006-0503-6
- By:
- Publication type:
- Article
Mitoxantrone versus cyclophosphamide in secondary-progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2006, v. 253, n. 8, p. 1034, doi. 10.1007/s00415-006-0154-7
- By:
- Publication type:
- Article
The clinical impact of interferon beta antibodies in relapsing-remitting MS.
- Published in:
- Journal of Neurology, 2004, v. 251, n. 3, p. 305, doi. 10.1007/s00415-004-0312-8
- By:
- Publication type:
- Article
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2003, v. 250, n. 7, p. 834, doi. 10.1007/s00415-003-1089-x
- By:
- Publication type:
- Article
Retrospective study of a large population of patients affected with mitochondrial disorders: clinical, morphological and molecular genetic evaluation.
- Published in:
- Journal of Neurology, 2001, v. 248, n. 9, p. 778, doi. 10.1007/s004150170094
- By:
- Publication type:
- Article
Cortical lesion load associates with progression of disability in multiple sclerosis.
- Published in:
- Brain: A Journal of Neurology, 2012, v. 135, n. 10, p. 2952, doi. 10.1093/brain/aws246
- By:
- Publication type:
- Article
Accuracy of Bioelectrical Impedance Analysis in Estimation of Extracellular Space in Healthy Subjects and in Fluid Retention States.
- Published in:
- Annals of Nutrition & Metabolism, 1994, v. 38, n. 3, p. 158, doi. 10.1159/000177806
- By:
- Publication type:
- Article
The changing clinical course of multiple sclerosis: A matter of gray matter.
- Published in:
- Annals of Neurology, 2013, v. 74, n. 1, p. 76, doi. 10.1002/ana.23882
- By:
- Publication type:
- Article
Reply.
- Published in:
- Annals of Neurology, 2011, v. 70, n. 1, p. 181, doi. 10.1002/ana.22465
- By:
- Publication type:
- Article
Reply.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 6, p. 1063, doi. 10.1002/ana.22411
- By:
- Publication type:
- Article
No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset.
- Published in:
- Annals of Neurology, 2011, v. 69, n. 1, p. 90, doi. 10.1002/ana.22228
- By:
- Publication type:
- Article
A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
- Published in:
- Annals of Neurology, 2010, v. 67, n. 3, p. 376, doi. 10.1002/ana.21906
- By:
- Publication type:
- Article
Disability trajectories by progression independent of relapse activity status differ in pediatric, adult and late-onset multiple sclerosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6782, doi. 10.1007/s00415-024-12638-0
- By:
- Publication type:
- Article
The contribution of paramagnetic rim and cortical lesions to physical and cognitive disability at multiple sclerosis clinical onset: evaluating the power of MRI and OCT biomarkers.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 10, p. 6702, doi. 10.1007/s00415-024-12622-8
- By:
- Publication type:
- Article
Effectiveness of teriflunomide on No Evidence of Disease Activity and cognition in relapsing remitting multiple sclerosis: results of the NEDA3PLUS study.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 10, p. 4687, doi. 10.1007/s00415-023-11820-0
- By:
- Publication type:
- Article
Neurodegeneration in the retina of motoneuron diseases: a longitudinal study in amyotrophic lateral sclerosis and Kennedy's disease.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 9, p. 4478, doi. 10.1007/s00415-023-11802-2
- By:
- Publication type:
- Article
Retinal inner nuclear layer thinning is decreased and associates with the clinical outcome in ocrelizumab-treated primary progressive multiple sclerosis.
- Published in:
- Journal of Neurology, 2022, v. 269, n. 10, p. 5436, doi. 10.1007/s00415-022-11183-y
- By:
- Publication type:
- Article
Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Cerebellar gray matter lesions are common in pediatric multiple sclerosis at clinical onset.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 6, p. 1824, doi. 10.1007/s00415-020-09776-6
- By:
- Publication type:
- Article
No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 1, p. 100, doi. 10.1007/s00415-019-09554-z
- By:
- Publication type:
- Article
Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration.
- Published in:
- Behavioral Sciences (2076-328X), 2023, v. 13, n. 9, p. 708, doi. 10.3390/bs13090708
- By:
- Publication type:
- Article
Sexual Dysfunction in Multiple Sclerosis: The Role of Executive Function.
- Published in:
- Behavioral Sciences (2076-328X), 2023, v. 13, n. 5, p. 369, doi. 10.3390/bs13050369
- By:
- Publication type:
- Article
Signs and symptoms of COVID‐19 in patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 12, p. 3728, doi. 10.1111/ene.15554
- By:
- Publication type:
- Article
The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis.
- Published in:
- European Journal of Neurology, 2022, v. 29, n. 2, p. 535, doi. 10.1111/ene.15167
- By:
- Publication type:
- Article
Long-term treatment with the dual antithromboxane agent picotamide decreases microalbuminuria in normotensive type 2 diabetic patients.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2010, v. 16, n. 10, p. 1220, doi. 10.1177/1352458510376405
- By:
- Publication type:
- Article
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis (13524585), 2009, v. 15, n. 11, p. 1359, doi. 10.1177/1352458509107011
- By:
- Publication type:
- Article
Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study.
- Published in:
- Multiple Sclerosis International, 2015, v. 2015, p. 1, doi. 10.1155/2015/369348
- By:
- Publication type:
- Article
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
- Published in:
- Multiple Sclerosis International, 2012, p. 1, doi. 10.1155/2012/760254
- By:
- Publication type:
- Article
Decreased platelet number in multiple sclerosis during alemtuzumab infusion: a common, transient and clinically silent phenomenon.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2018, v. 11, p. 1, doi. 10.1177/1756285617741056
- By:
- Publication type:
- Article
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project.
- Published in:
- Neurology & Therapy, 2024, v. 13, n. 5, p. 1415, doi. 10.1007/s40120-024-00644-3
- By:
- Publication type:
- Article
D-KEFS ST Failure Identifies Multiple Sclerosis Patients With Worse Objective and Self-Perceived Physical and Cognitive Disability.
- Published in:
- Frontiers in Psychology, 2019, p. N.PAG, doi. 10.3389/fpsyg.2019.00049
- By:
- Publication type:
- Article